Skip to main content
. 2016 Feb 12;7(11):12904–12916. doi: 10.18632/oncotarget.7354

Table 1A. Mean intensities and variations of the most significant metabolites found in the comparison between healthy individuals and NSCLC patients.

Metabolite δ 1H (ppm)a Mean spectral intensity ± s.e.m. (arbitrary units) % variation P-valueb
Healthy Group NSCLC patients
HDL (CH3) 0.85-0.79 55.14 ± 1.50 45.55 ± 0.73 −17.39 0.0000*
VLDL (CH3) 0.91-0.85 66.10 ± 1.49 65.17 ± 0.78 −1.40 0.9070
Leucine/Isoleucine 0.97-0.91 14.40 ± 0.25 16.67 ± 0.26 15.75 0.0000*
3-hydroxybutyrate 1.20-1.18 8.22 ± 0.15 8.60 ± 0.20 4.59 0.8585
LDL/VLDL (CH2)n 1.31-1.20 229.06 ± 6.10 197.77 ± 3.26 −13.66 0.0001*
Unknown 1 1.40-1.36 4.01 ± 0.11 5.04 ± 0.14 25.65 0.0000*
Adipic acid 1.60-1.52 15.97 ± 0.69 13.79 ± 0.34 −13.64 0.0406*
Acetate 1.91-1.90 1.29 ± 0.04 1.56 ± 0.04 21.22 0.0001*
Lipids (CH2-C=C) 2.02-1.93 40.15 ± 0.46 35.56 ± 0.31 −11.44 0.0000*
N-Acetyl-cysteine 2.05-2.02 23.50 ± 0.32 27.01 ± 0.44 14.94 0.0000*
Lipids (CH2-CO) 2.26-2.19 14.19 ± 0.65 13.17 ± 0.30 −7.15 0.5775
Glutamate 2.36-2.33 2.14 ± 0.07 2.95 ± 0.07 37.65 0.0000*
Glutamine 2.47-2.41 5.82 ± 0.19 4.98 ± 0.11 −14.37 0.0002*
Choline–N(CH3)3+ 3.21-3.18 23.56 ± 0.67 17.60 ± 0.34 −25.30 0.0000*
Methanol 3.36-3.35 1.01 ± 0.05 1.81 ± 0.05 78.81 0.0000*
Glycerol 3.80-3.78 2.90 ± 0.09 3.63 ± 0.08 25.16 0.0000*
Creatine 3.92-3.91 0.90 ± 0.04 1.20 ± 0.03 33.82 0.0000*
Lactate 4.13-4.08 10.45 ± 0.38 13.74 ± 0.42 31.53 0.0000*
Threonine 4.30-4.21 6.92 ± 0.12 5.86 ± 0.09 −15.34 0.0000*
Glucose 5.24-5.21 11.92 ± 0.35 12.63 ± 0.26 5.92 0.2202
Lipids (CH=CH) 5.37-5.24 32.92 ± 0.75 28.08 ± 0.45 −14.70 0.0000*
Histidine 7.78-7.74 0.37 ± 0.01 0.29 ± 0.01 −20.76 0.0000*
a

Chemical shift region used for quantification

b

P-value calculated using the Mann–Whitney-Wilcoxon test

*

Statistically significant (P < 0.05)